Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verosudil vs Timolol Adjunct to Latanoprost in Glaucoma/OHT
NCT01302249Phase 2Completed
- Sponsor
- Aerie Pharmaceuticals
- Start
- Feb 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verosudil in Glaucoma, ocular hypertension, sponsored by Aerie Pharmaceuticals. Started Feb 2011; status: completed.
02
Drugs
verosudil
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT01302249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302249.